Tianjin (1)

Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (1)

Active, not recruiting (1)

early phase 1 (1)

Institute of Hematology & Blood Diseases Hospital (1)

Juventas Cell Therapy Ltd. (1)

cd19-cd22 car-t cells (1)

biological (1)

Other (1)

Interventional (1)

relapsed or refractory b cell acute lymphoblastic leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Aug 2, 2022